A RCT was conducted to test the efficacy of a new failure he…
A RCT was conducted to test the efficacy of a new failure heart medication compared to placebo to prevent major adverse cardiac events (MACE). The new medication was found to decrease MACE compared to placebo (RR 0.74; 95%CI 0.46 to 1.02). How is this best interpreted?